drugset / Trial / NCT05604131

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

NCT05604131

RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.

Timeline

Start
2022-11-08
Primary completion
2029-03-31
Completion
2029-08-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Deferiprone Small molecule